Physician profile
Maria E Smith
NPI 1285890517
$986.70
in general payments reported to CMS, 2019-2025
16 companies · $596 in 2025
The $596 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.90 · 2021: $24.41 · 2022: $31.47 · 2023: $48.59 · 2024: $270 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $283.84 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $135.15 | 2024-2025 | Krystexxa |
| Pfizer INC. | $124.21 | 2021-2025 | |
| Corcept Therapeutics | $76.97 | 2025 | Korlym |
| Lilly USA, LLC | $60.92 | 2025 | Mounjaro, Zepbound |
| Abbvie INC. | $56.67 | 2024-2025 | |
| Exact Sciences Corporation | $38.75 | 2025 | The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.31 | 2025 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $32.56 | 2025 | Rexulti |
| Lundbeck LLC | $31.24 | 2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $21.12 | 2025 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.86 | 2024 | Jardiance |
| Aimmune Therapeutics, INC. | $20.60 | 2024 | |
| Glaxosmithkline, LLC. | $18.49 | 2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $16.09 | 2024 | Airsupra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.92 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.